Protective Role of Natural Products in Cisplatin-Induced Nephrotoxicity

被引:50
作者
Ridzuan, Nurul Raudzah Adib [1 ]
Abd Rashid, Norhashima [2 ]
Othm, Faizah [1 ]
Budin, Siti Balkis [2 ]
Hussan, Farida [3 ]
Teoh, Soong Lin [1 ]
机构
[1] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Anat, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, Fac Hlth Sci, Biomed Sci Program, Kuala Lumpur, Malaysia
[3] Int Med Univ, Sch Med, Human Biol Div, Kuala Lumpur, Malaysia
关键词
Cancer; natural product; cisplatin; toxicity; kidney; nephrotoxicity; FERMENTED BLACK GINSENG; DNA-DAMAGE RESPONSE; ACUTE KIDNEY INJURY; GRAPE SEED EXTRACT; GLYCYRRHIZIC ACID; IN-VITRO; OXIDATIVE STRESS; INDUCED TOXICITY; RENAL INJURY; CURCUMIN;
D O I
10.2174/1389557519666190320124438
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cisplatin is a widely used antineoplastic agent for the treatment of metastatic tumors, advanced bladder cancer and many other solid tumors. However, at higher doses, toxicities such as nephrotoxicity may appear. Cisplatin leads to DNA damage and subsequently renal cell death. Besides that, oxidative stress is also implicated as one of the main causes of nephrotoxicity. Several studies showed that numerous natural products: ginseng, curcumin, licorice, honey and pomegranate were able to reduce the oxidative stress by restoring the levels of antioxidant enzymes and also at the same time act as an anti-inflammatory agent. Furthermore, pre-treatment with vitamin supplementation, such as vitamin C, E and riboflavin markedly decreased serum urea and increased the levels of antioxidant enzymes in the kidney even after cisplatin induction in cancer patients. These natural products possess potent antioxidant and anti-inflammatory medicinal properties, and they can be safely used as a supplementary regime or combination therapy against cisplatin-induced nephrotoxicity. The present review focused on the protective role of a few natural products which is widely used in folk medicines in cisplatin-induced nephrotoxicity.
引用
收藏
页码:1134 / 1143
页数:10
相关论文
共 81 条
[61]   Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity [J].
Sahu, Bidya Dhar ;
Rentam, Kiran Kumar Reddy ;
Putcha, Uday Kumar ;
Kuncha, Madhusudana ;
Vegi, Ganga Modi Naidu ;
Sistla, Ramakrishna .
FOOD AND CHEMICAL TOXICOLOGY, 2011, 49 (12) :3090-3097
[62]   Protective effect of dietary azuki bean (Vigna angularis) seed coats against renal interstitial fibrosis of rats induced by cisplatin [J].
Sato, S ;
Hori, Y ;
Yamate, J ;
Saito, T ;
Kurasaki, M ;
Hatai, A .
NUTRITION, 2005, 21 (04) :504-511
[63]  
Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967
[64]   Cisplatin-induced nephrotoxicity in mice: protective role of Leea asiatica leaves [J].
Sen, Saikat ;
De, Biplab ;
Devanna, N. ;
Chakraborty, Raja .
RENAL FAILURE, 2013, 35 (10) :1412-1417
[65]   Pomegranate Use to Attenuate Bone Loss in Major Musculoskeletal Diseases: An Evidence-Based Review [J].
Shuid, Ahmad Nazrun ;
Mohamed, Isa Naina .
CURRENT DRUG TARGETS, 2013, 14 (13) :1565-1578
[66]   Protective Effect of Tetrahydrocurcumin against Cisplatin-Induced Renal Damage: In Vitro and In Vivo Studies [J].
Song, Kyung Il ;
Park, Jun Yeon ;
Lee, Seungyong ;
Lee, Dahae ;
Jang, Hyuk-Jai ;
Kim, Su-Nam ;
Ko, Hyeonseok ;
Kim, Hyun Young ;
Lee, JaeWook ;
Hwang, Gwi Seo ;
Kang, Ki Sung ;
Yamabe, Noriko .
PLANTA MEDICA, 2015, 81 (04) :286-291
[67]   Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis [J].
Topcu-Tarladacalisir, Yeter ;
Sapmaz-Metin, Melike ;
Karaca, Turan .
RENAL FAILURE, 2016, 38 (10) :1741-1748
[68]   Cisplatin Overdose Toxicities and Management [J].
Tsang, Roger Y. ;
Al-Fayea, Turki ;
Au, Heather-Jane .
DRUG SAFETY, 2009, 32 (12) :1109-1122
[69]   Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice [J].
Ueki, Masaaki ;
Ueno, Masaki ;
Morishita, Jun ;
Maekawa, Nobuhiro .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2013, 115 (05) :547-551
[70]  
Ulu R, 2016, INT J CLIN EXP MED, V9, P19623